Yingli Pharma Announces a presentation on the Phase 2 clinical trial of linperlisib, a PI3Kδ …,

In addition, linperlisib received FDA Orphan Drug Designations for FL, CLL/SLL, and T cell lymphoma. A clinical trial in r/r FL is launching in the US., In addition, linperlisib received FDA Orphan Drug Designations for FL, CLL/SLL, and T cell lymphoma. A clinical trial in r/r FL is launching in the US., Read More

Scroll to Top